Marketing-authorisation holder · Canada
Altius Healthcare Inc
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CLÉO -352 mg + 0.035 mg · Tablet | Cyproterone, Ethinyl estradiol | Canada | Marketed | 2015 |
| DEXLANSOPRAZOLE60 mg · Capsule (Delayed-Release) | Dexlansoprazole | Canada | Cancelled | 2024 |
| DEXLANSOPRAZOLE30 mg · Capsule (Delayed-Release) | Dexlansoprazole | Canada | Cancelled | 2024 |
| PANTOPRAZOLE MAGNESIUM40 mg · Tablet (Enteric-Coated) | Pantoprazole | Canada | Cancelled | 2015 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 4 | 1 | 3 | CompaniesAll medicines |